Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01008644
Other study ID # M-126-09
Secondary ID
Status Completed
Phase Phase 0
First received November 5, 2009
Last updated October 15, 2012
Start date November 2009
Est. completion date November 2010

Study information

Verified date October 2012
Source Kalmar County Hospital
Contact n/a
Is FDA regulated No
Health authority Sweden: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Primary hypothesis: osmolality changes influence the sensitivity of the respiratory center to carbon dioxide, hyponatraemia causing hyperventilation, and hypernatraemia depressing ventilation.

Secondary hypothesis: There are gender differences in the sensitivity to osmolality changes.

10 women and 10 men will on different occasions drink water or receive hypertonic saline intravenously, in order to lower or increase plasma osmolality. The women will participate during both faces of the menstruation cycle. On each occasion the subject´s sensitivity to carbon dioxide will be tested, and blood samples will be drawn for analysis of blood gases,electrolyte and osmolality.Subjects who interrupt participation before completion of all planned occasions, will be substituted, so that 10 subjects of either sex will have participated as planned. All results from all participants will be analyzed.


Description:

Healthy volunteers will on different occasions be subject to reduced plasma osmolality caused by drinking water, and increased osmolality caused by intravenous infusion of hypertonic saline.Before and after each osmolality change, sensitivity to carbon dioxide will be tested by partial rebreathing through a so called Bain-system. Throughout the whole experiment heart rate, blood pressure and oxygen saturation will be recorded.Blood samples will be collected before each rebreathing test and every 20 minutes during the two hours of water or salt load. Urine will be collected and analysed.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date November 2010
Est. primary completion date November 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Females with regular menstruations, males

Exclusion Criteria:

- Consumption of nicotine, BMI > 26,

- pregnancy,any hormone treatment,

- treatment with diuretics,

- diabetes or kidney disease,

- BMI > 26,

Study Design

Allocation: Non-Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Water
The subjects will drink tap water for 2 hours, volume calculated according to weight: 20ml/kg/hour.
Saline 3%
The subjects will receive saline 3% intravenously for 2 hours, the volume calculated as 0.1 ml/kg/min

Locations

Country Name City State
Sweden Department of Anaesthesia and Intensive care, Kalmar County Hospital Kalmar

Sponsors (1)

Lead Sponsor Collaborator
Vibeke Moen

Country where clinical trial is conducted

Sweden, 

References & Publications (3)

Heenan AP, Wolfe LA. Plasma osmolality and the strong ion difference predict respiratory adaptations in pregnant and nonpregnant women. Can J Physiol Pharmacol. 2003 Sep;81(9):839-47. — View Citation

Jennings DB. The physicochemistry of [H+] and respiratory control: roles of PCO2, strong ions, and their hormonal regulators. Can J Physiol Pharmacol. 1994 Dec;72(12):1499-512. Review. — View Citation

Weissgerber TL, Wolfe LA, Hopkins WG, Davies GA. Serial respiratory adaptations and an alternate hypothesis of respiratory control in human pregnancy. Respir Physiol Neurobiol. 2006 Aug;153(1):39-53. Epub 2005 Nov 28. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary pCO2 pCO2,osmolality and sensitivity to CO2 will be recorded 10 minutes before before and 10 minutes after administering water or saline for two hours.The results will be analyzed for differences before and after osmolality changes in every single individual, and differences between females in luteal or follicular menstruation phase. ten minutes No
See also
  Status Clinical Trial Phase
Completed NCT01974739 - Hydrochloorthiazide and Hypernatriaemie N/A